263 related articles for article (PubMed ID: 33728801)
21. Evaluation of the efficacy of fractional CO
Sindou-Faurie T; Louis-Vahdat C; Oueld Es Cheikh E; Canlorbe G; Mergui JL; Uzan C; Azaïs H
Arch Gynecol Obstet; 2021 Apr; 303(4):955-963. PubMed ID: 33179118
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause.
Barba M; Cola A; De Vicari D; Costa C; Castelli AP; Volontè S; Fruscio R; Frigerio M
Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892888
[TBL] [Abstract][Full Text] [Related]
23. Vaginal Laser Treatment for the Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Narrative Review.
Okui N
Cureus; 2023 Sep; 15(9):e45495. PubMed ID: 37731685
[TBL] [Abstract][Full Text] [Related]
24. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
Gambacciani M; Levancini M
Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
[TBL] [Abstract][Full Text] [Related]
25. Use of a vaginal CO
Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
[TBL] [Abstract][Full Text] [Related]
26. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
27. Fractional CO
Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
[TBL] [Abstract][Full Text] [Related]
28. Fractional CO
Becorpi A; Campisciano G; Zanotta N; Tredici Z; Guaschino S; Petraglia F; Pieralli A; Sisti G; De Seta F; Comar M
Lasers Med Sci; 2018 Jul; 33(5):1047-1054. PubMed ID: 29492713
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update.
Merlino L; D'Ovidio G; Matys V; Piccioni MG; Porpora MG; Senatori R; Viscardi MF; Vitale A; Della Rocca C; On Behalf Of Policlinico Umberto I Collaborators
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111307
[TBL] [Abstract][Full Text] [Related]
30. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
Mothes AR; Runnebaum M; Runnebaum IB
J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of fractional CO
Quick AM; Dockter T; Le-Rademacher J; Salani R; Hudson C; Hundley A; Terstriep S; Streicher L; Faubion S; Loprinzi CL; Coleman JS; Wang KC; Lustberg M
Maturitas; 2021 Feb; 144():37-44. PubMed ID: 33358206
[TBL] [Abstract][Full Text] [Related]
32. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment.
Mezzana P
Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352
[TBL] [Abstract][Full Text] [Related]
33. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
Wallace SL; St Martin B; Lee K; Sokol ER
Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
[TBL] [Abstract][Full Text] [Related]
34. Fractional CO
Chung YJ; Shim S; Kim S; Cha J; Song JY; Kim MJ; Kim MR
J Clin Med; 2023 May; 12(11):. PubMed ID: 37297874
[TBL] [Abstract][Full Text] [Related]
35. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review.
Jugulytė N; Žukienė G; Bartkevičienė D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676756
[TBL] [Abstract][Full Text] [Related]
36. Fractional Microablative CO
Pagano T; Travaglino A; Raffone A; Vallone R; Buonfantino C; De Rosa P; Locci M; Guadagno E; Insabato L; Salvatore S; De Placido G
Lasers Surg Med; 2021 Apr; 53(4):521-527. PubMed ID: 32797701
[TBL] [Abstract][Full Text] [Related]
37. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM
World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
[TBL] [Abstract][Full Text] [Related]
38. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
39. Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.
Sussman TA; Kruse ML; Thacker HL; Abraham J
J Oncol Pract; 2019 Jul; 15(7):363-370. PubMed ID: 31291563
[TBL] [Abstract][Full Text] [Related]
40. Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies.
Castelo-Branco C; Mension E; Torras I; Cebrecos I; Anglès-Acedo S
Climacteric; 2023 Aug; 26(4):296-301. PubMed ID: 36946290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
